More Argent Biopharma Ltd news
Argent Biopharma LtdASX: RGT

MGC pharma 2021 clinical trials program update

May 24, 2021 at 11:41 PM EDT · Issued by Argent Biopharma Ltd

Filed with ASX · May 24, 2021 at 11:41 PM EDT · 3 pages · English

On 6ix: 6ix.com/news/mgc-pharma-2021-clinical-trials-program-update

Argent Biopharma Ltd on 6ix

Earlier from Argent Biopharma

  • CimetrA patent submitted to European IP officeMay 17, 2021
  • Further findings on ArtemiC as anti-inflammatory agentMay 7, 2021
  • $1M order for ArtemiC Rescue from swiss PharmaCanMay 3, 2021
  • ArtemiC submitted to Health CanadaApr 28, 2021
  • March quarterly activity and cashflow reportApr 26, 2021

Later from Argent Biopharma

  • CannEpil available for free dispensing in irelandJun 14, 2021
  • 1St patient recruited into CimetrA phase 3 clinical trialJul 12, 2021
  • Patent application lodged for novel drug delivery systemJul 15, 2021
  • MGC pharma executes US$24M US supply agreementAug 26, 2021
  • Cimetra import approval granted for indiaSep 3, 2021
All Argent Biopharma news releases↗

Follow Argent Biopharma into a list and get an email when it puts out news.

Follow Argent Biopharma
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer